首页 > 最新文献

Clinical Diabetology最新文献

英文 中文
Effects of Diabetes Technologies on Decision Making Feedback Loop in Type 1 Diabetes 糖尿病技术对1型糖尿病决策反馈回路的影响
IF 0.7 Q4 Medicine Pub Date : 2023-02-28 DOI: 10.5603/dk.a2022.0065
K. Karakuş
{"title":"Effects of Diabetes Technologies on Decision Making Feedback Loop in Type 1 Diabetes","authors":"K. Karakuş","doi":"10.5603/dk.a2022.0065","DOIUrl":"https://doi.org/10.5603/dk.a2022.0065","url":null,"abstract":"","PeriodicalId":10386,"journal":{"name":"Clinical Diabetology","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2023-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76762344","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Do We Need Another Guideline on Managing Type 2 Diabetes in India? 在印度,我们需要另一个管理2型糖尿病的指南吗?
IF 0.7 Q4 Medicine Pub Date : 2023-02-28 DOI: 10.5603/dk.a2023.0002
P. Gangadhar, Gaurav Palikhe
{"title":"Do We Need Another Guideline on Managing Type 2 Diabetes in India?","authors":"P. Gangadhar, Gaurav Palikhe","doi":"10.5603/dk.a2023.0002","DOIUrl":"https://doi.org/10.5603/dk.a2023.0002","url":null,"abstract":"","PeriodicalId":10386,"journal":{"name":"Clinical Diabetology","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2023-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73826310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Promise of Diabetes Technologies 糖尿病技术的前景
IF 0.7 Q4 Medicine Pub Date : 2023-02-28 DOI: 10.5603/dk.a2023.0001
O. Ebekozien, H. Hardison, Viral N Shah
{"title":"The Promise of Diabetes Technologies","authors":"O. Ebekozien, H. Hardison, Viral N Shah","doi":"10.5603/dk.a2023.0001","DOIUrl":"https://doi.org/10.5603/dk.a2023.0001","url":null,"abstract":"","PeriodicalId":10386,"journal":{"name":"Clinical Diabetology","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2023-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78999397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Significant Improvement in Glycemic Control after Initiation of AHCL in Children with Type 1 Diabetes: A Single Center Prospective Study 1型糖尿病儿童AHCL治疗后血糖控制显著改善:一项单中心前瞻性研究
IF 0.7 Q4 Medicine Pub Date : 2023-02-28 DOI: 10.5603/dk.a2022.0063
G. Yeşiltepe Mutlu, Elif Eviz, Ecem Can, Tugba Gokce, Serra Muradoğlu, Ş. Hatun
{"title":"Significant Improvement in Glycemic Control after Initiation of AHCL in Children with Type 1 Diabetes: A Single Center Prospective Study","authors":"G. Yeşiltepe Mutlu, Elif Eviz, Ecem Can, Tugba Gokce, Serra Muradoğlu, Ş. Hatun","doi":"10.5603/dk.a2022.0063","DOIUrl":"https://doi.org/10.5603/dk.a2022.0063","url":null,"abstract":"","PeriodicalId":10386,"journal":{"name":"Clinical Diabetology","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2023-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87873890","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
“My Friend Diabetes Carbohydrate-Bolus Calculator”: User Experiences of a Bolus Calculating Carbohydrate Counting Mobile App for People with Type 1 Diabetes “我的朋友糖尿病碳水化合物丸计算器”:1型糖尿病患者的碳水化合物丸计算移动应用程序的用户体验
IF 0.7 Q4 Medicine Pub Date : 2023-02-28 DOI: 10.5603/dk.a2022.0066
K. Karakuş, Tugba Gokce, Serra Muradoğlu, Ecem Can, Elif Eviz, G. Yeşiltepe Mutlu, Ş. Hatun
{"title":"“My Friend Diabetes Carbohydrate-Bolus Calculator”: User Experiences of a Bolus Calculating Carbohydrate Counting Mobile App for People with Type 1 Diabetes","authors":"K. Karakuş, Tugba Gokce, Serra Muradoğlu, Ecem Can, Elif Eviz, G. Yeşiltepe Mutlu, Ş. Hatun","doi":"10.5603/dk.a2022.0066","DOIUrl":"https://doi.org/10.5603/dk.a2022.0066","url":null,"abstract":"","PeriodicalId":10386,"journal":{"name":"Clinical Diabetology","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2023-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78702394","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Erythrocyte Sedimentation Rate is a Simple, Sensitive and Predictive Hematological Index for Non-Septic Diabetic Foot Syndrome: A Cross-Sectional Study 红细胞沉降率是一种简单、敏感和预测非脓毒性糖尿病足综合征的血液学指标:一项横断面研究
IF 0.7 Q4 Medicine Pub Date : 2022-12-28 DOI: 10.5603/dk.a2022.0052
Marwan S. Al-Nimer, R. Ratha
{"title":"The Erythrocyte Sedimentation Rate is a Simple, Sensitive and Predictive Hematological Index for Non-Septic Diabetic Foot Syndrome: A Cross-Sectional Study","authors":"Marwan S. Al-Nimer, R. Ratha","doi":"10.5603/dk.a2022.0052","DOIUrl":"https://doi.org/10.5603/dk.a2022.0052","url":null,"abstract":"","PeriodicalId":10386,"journal":{"name":"Clinical Diabetology","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2022-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78916937","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
A Comprehensive Review on the Metabolic Cooperation Role of Nuclear Factor E2-Related Factor 2 and Fibroblast Growth Factor 21 against Homeostasis Changes in Diabetes 核因子e2相关因子2和成纤维细胞生长因子21在糖尿病体内平衡变化中的代谢协同作用综述
IF 0.7 Q4 Medicine Pub Date : 2022-12-28 DOI: 10.5603/dk.a2022.0051
Bahar Kiani, Sahar Yarahmadi, M. Nabi-Afjadi, Hanie Eskandari, Maryam Hasani, Z. Abbasian, E. Bahreini
{"title":"A Comprehensive Review on the Metabolic Cooperation Role of Nuclear Factor E2-Related Factor 2 and Fibroblast Growth Factor 21 against Homeostasis Changes in Diabetes","authors":"Bahar Kiani, Sahar Yarahmadi, M. Nabi-Afjadi, Hanie Eskandari, Maryam Hasani, Z. Abbasian, E. Bahreini","doi":"10.5603/dk.a2022.0051","DOIUrl":"https://doi.org/10.5603/dk.a2022.0051","url":null,"abstract":"","PeriodicalId":10386,"journal":{"name":"Clinical Diabetology","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2022-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72599583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Type 2 Diabetes as a Factor Modifying the Course and Prognosis of Acute Pancreatitis 2型糖尿病是改变急性胰腺炎病程和预后的一个因素
IF 0.7 Q4 Medicine Pub Date : 2022-12-28 DOI: 10.5603/dk.a2022.0057
Anna Rostropowicz-Honka, Z. Brzoza
{"title":"Type 2 Diabetes as a Factor Modifying the Course and Prognosis of Acute Pancreatitis","authors":"Anna Rostropowicz-Honka, Z. Brzoza","doi":"10.5603/dk.a2022.0057","DOIUrl":"https://doi.org/10.5603/dk.a2022.0057","url":null,"abstract":"","PeriodicalId":10386,"journal":{"name":"Clinical Diabetology","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2022-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72954179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Association between Pandemic Isolation and Glycemic Control and Biochemistry Parameters in Patients with Type 2 Diabetes 大流行隔离与2型糖尿病患者血糖控制及生化指标的关系
IF 0.7 Q4 Medicine Pub Date : 2022-12-28 DOI: 10.5603/dk.a2022.0059
Merve İncekara, Özlem Suvak
Objective: COVID-19 lockdown caused many people with chronic diseases to delay their follow-up and worsen their metabolic parameters. This study aimed to investigate the effect of the COVID-19 pandemic period on the glycemic control and biochemistry parameters of patients with type 2 diabetes mellitus (T2DM). Material(s) and Method(s): The data of 347 T2DM patients covering the period before and after the lockdown (March-June 2020) was retrospectively analyzed. HbA1c and fasting plasma glucose (FPG), renal function tests and microalbuminuria measurements were compared. All statistical analyses and power analysis were performed with IBM SPSS Statistics version 23.0. Result(s): Of 347 patients, 216 (62.2%) were female and the mean age was 58.82 +/- 10.47 years. One hundred eighty five (53.3%) of the individuals have been using insulin and oral antidiabetic together and those treated with insulin alone were excluded at the data collection phase of the study. HbA1c, FPG, urea, creatinine, microalbumin in spot urine and alb/crea in spot urine increased in the pandemic period compared to pre-pandemic period, creatinine measurement decreased in spot urine (p < 0.05) except the ketone in urine between the two periods. HbA1c (r = 0.728, p < 0.01), creatinine (r = 0.8458, p < 0.01), microalbumin in spot urine (r = 0.773, p < 0.01) and spot urine alb/crea (r = 0.796, p < 0.01) measurements were highly, positive and statistically significant. Conclusion(s): As in all chronic diseases, T2DM patients should be followed up regularly in order to prevent morbidities in extraordinary situations such as pandemics. Copyright © 2022 Via Medica. All rights reserved.
目的:新冠肺炎封锁导致许多慢性病患者随访时间延迟,代谢参数恶化。本研究旨在探讨新冠肺炎大流行期对2型糖尿病(T2DM)患者血糖控制及生化指标的影响。材料和方法:回顾性分析封锁前后(2020年3月至6月)347例T2DM患者的数据。比较HbA1c、空腹血糖(FPG)、肾功能和微量蛋白尿测定。所有统计分析和功效分析均使用IBM SPSS Statistics version 23.0进行。结果:347例患者中,女性216例(62.2%),平均年龄58.82±10.47岁。185人(53.3%)同时使用胰岛素和口服抗糖尿病药物,在研究的数据收集阶段排除了单独使用胰岛素治疗的患者。与流行前相比,流行期HbA1c、FPG、尿素、肌酐、斑点尿微量白蛋白和斑点尿alb/crea值升高,斑点尿肌酐值下降,但两期尿酮值比较差异有统计学意义(p < 0.05)。HbA1c (r = 0.728, p < 0.01)、肌酐(r = 0.8458, p < 0.01)、斑点尿微量白蛋白(r = 0.773, p < 0.01)、斑点尿alb/crea (r = 0.796, p < 0.01)均呈高阳性,且有统计学意义。结论:与所有慢性疾病一样,2型糖尿病患者应定期随访,以防止在特殊情况下(如流行病)发病。版权所有©2022 Via Medica版权所有。
{"title":"The Association between Pandemic Isolation and Glycemic Control and Biochemistry Parameters in Patients with Type 2 Diabetes","authors":"Merve İncekara, Özlem Suvak","doi":"10.5603/dk.a2022.0059","DOIUrl":"https://doi.org/10.5603/dk.a2022.0059","url":null,"abstract":"Objective: COVID-19 lockdown caused many people with chronic diseases to delay their follow-up and worsen their metabolic parameters. This study aimed to investigate the effect of the COVID-19 pandemic period on the glycemic control and biochemistry parameters of patients with type 2 diabetes mellitus (T2DM). Material(s) and Method(s): The data of 347 T2DM patients covering the period before and after the lockdown (March-June 2020) was retrospectively analyzed. HbA1c and fasting plasma glucose (FPG), renal function tests and microalbuminuria measurements were compared. All statistical analyses and power analysis were performed with IBM SPSS Statistics version 23.0. Result(s): Of 347 patients, 216 (62.2%) were female and the mean age was 58.82 +/- 10.47 years. One hundred eighty five (53.3%) of the individuals have been using insulin and oral antidiabetic together and those treated with insulin alone were excluded at the data collection phase of the study. HbA1c, FPG, urea, creatinine, microalbumin in spot urine and alb/crea in spot urine increased in the pandemic period compared to pre-pandemic period, creatinine measurement decreased in spot urine (p < 0.05) except the ketone in urine between the two periods. HbA1c (r = 0.728, p < 0.01), creatinine (r = 0.8458, p < 0.01), microalbumin in spot urine (r = 0.773, p < 0.01) and spot urine alb/crea (r = 0.796, p < 0.01) measurements were highly, positive and statistically significant. Conclusion(s): As in all chronic diseases, T2DM patients should be followed up regularly in order to prevent morbidities in extraordinary situations such as pandemics. Copyright © 2022 Via Medica. All rights reserved.","PeriodicalId":10386,"journal":{"name":"Clinical Diabetology","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2022-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81940228","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Finerenone in SGLT-2 Inhibitors Era: Current Positioning in Diabetic Kidney Disease 芬烯酮在SGLT-2抑制剂时代:目前在糖尿病肾病中的定位
IF 0.7 Q4 Medicine Pub Date : 2022-12-28 DOI: 10.5603/dk.a2022.0041
A. K. Singh, Ritu Singh, Viral N Shah, Anoop Misra
{"title":"Finerenone in SGLT-2 Inhibitors Era: Current Positioning in Diabetic Kidney Disease","authors":"A. K. Singh, Ritu Singh, Viral N Shah, Anoop Misra","doi":"10.5603/dk.a2022.0041","DOIUrl":"https://doi.org/10.5603/dk.a2022.0041","url":null,"abstract":"","PeriodicalId":10386,"journal":{"name":"Clinical Diabetology","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2022-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88057283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical Diabetology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1